Dispute Resolution Strategies: FDA Clarifies Which Issues Can Be Appealed
Executive Summary
Matters ripe for appeal above review division level include denial of request for breakthrough therapy designation, revised guidance states, but general advice – such as how to conduct a clinical research program – are not appealable.